These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 6170375

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F, Motamed M.
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [Abstract] [Full Text] [Related]

  • 3. Mutual antagonism between nerve growth factor and substance P N-terminal activity on nociceptive activity in mice.
    Larson AA, Kitto KF.
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1345-50. PubMed ID: 9316845
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In the eye (D-Pro2, D-Trp7,9)-SP is a substance P agonist, which modifies the responses to substance P, prostaglandin E1 and antidromic trigeminal nerve stimulation.
    Mandahl A, Bill A.
    Acta Physiol Scand; 1983 Jan; 117(1):139-44. PubMed ID: 6190353
    [Abstract] [Full Text] [Related]

  • 8. Effects of concanavalin A on 5-hydroxytryptamine uptake by rabbit blood platelets and on their ultrastructure.
    Nishio H, Segawa T, Takagi H.
    Br J Pharmacol; 1979 Apr; 65(4):557-63. PubMed ID: 219926
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A, Bill A.
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM, Holmsen H.
    Thromb Haemost; 1984 Dec 29; 52(3):333-5. PubMed ID: 6099615
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Shape change reaction of platelets in protein-free medium: ultramorphology.
    Graf M, Richards JG, Colombo V, Pletscher A.
    Experientia; 1979 Jun 15; 35(6):840-2. PubMed ID: 467611
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.
    Born GV, Juengjaroen K, Michal F.
    Br J Pharmacol; 1972 Jan 15; 44(1):117-39. PubMed ID: 5015032
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.